Synthesis 2010(23): 4068-4074  
DOI: 10.1055/s-0030-1258275
PAPER
© Georg Thieme Verlag Stuttgart ˙ New York

Synthesis of 2-Amino-5-hydroxycaprolactam Derivatives Mediated by E-Selective Olefination and Asymmetric Oxidation of the Enol Ether

Hong Lia,c, Yingxue Liua, Qijun Liua,c, Wenhui Hua, Guo-Chun Zhou*a,b
a Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, P. R. of China
b College of Biotechnology and Pharmaceutical Engineering and College of Pharmaceutical Sciences, Nanjing University of Technology, Nanjing 210009, P. R. of China
Fax: +86(20)32015351; e-Mail: allspringzhou@yahoo.com;
c Graduate School of Chinese Academy of Sciences, Beijing 100039, P. R. of China
Further Information

Publication History

Received 5 August 2010
Publication Date:
30 September 2010 (online)

Abstract

The asymmetric synthesis of 2-amino-5-hydroxycaprolactam derivatives is essential for exploring the antitumor properties of ester-bearing bengamides. In this study, chiral caprolactam isomers were achieved on the basis of highly E-selective Wittig olefination, asymmetric oxidations of the E-enol ethers, reductive amination of the aldehyde derivatives, cyclization of the 5-hydroxy­lysine analogues or/and deprotection.

    References

  • 1a Quinoa E. Adamczeski M. Crews P. Bakus GJ.
    J. Org. Chem.  1986,  51:  4494 
  • 1b Adamczeski M. Quinoa E. Crews P. J. Am. Chem. Soc.  1989,  111:  647 
  • 2 Towbin H. Bair KW. DeCaprio JA. Eck MJ. Kim S. Kinder FR. Morollo A. Mueller DR. Schindler P. Song HK. van Oostrum J. Versace RW. Voshol H. Wood J. Zabludoff S. Phillips PE. J. Biol. Chem.  2003,  278:  52964 
  • 3a Thale Z. Kinder FR. Bair KW. Bontempo J. Czuchta AM. Versace RW. Phillips PE. Sanders ML. Wattanasin S. Crews P. J. Org. Chem.  2001,  66:  1733 
  • 3b Kinder FR. Versace RW. Bair KW. Bontempo JM. Cesarz D. Chen S. Crews P. Czuchta AM. Jagoe CT. Mou Y. Nemzek R. Phillips PE. Tran LD. Wang RM. Weltchek S. Zabludoff S. J. Med. Chem.  2001,  44:  3692 
  • 4 Kim S. LaMontagne K. Sabio M. Sharma S. Versace RW. Yusuff N. Phillips PE. Cancer Res.  2004,  64:  2984 
  • 5 Kinder FR. Wattanasin S. Versace RW. Bair KW. Bontempo J. Green MA. Lu YJ. Marepalli HR. Phillips PE. Roche D. Tran LD. Wang RM. Waykole L. Xu DD. Zabludoff S. J. Org. Chem.  2001,  66:  118 ; and references therein
  • 6a Löhr B. Orlich S. Kunz H. Synlett  1999,  139 
  • 6b Adamczyk M. Reddy RE. Rege SD. J. Labelled Compd. Radiopharm.  2001,  44:  185 
  • 6c van den Nieuwendijk AMCH. Kriek NMAJ. Brussee J. van Boom JH. van der Gen A. Eur. J. Org. Chem.  2000,  3683 
  • 7a Broka CA. Ehrler J. Tetrahedron Lett.  1991,  32:  5907 
  • 7b Roche D. Prasad K. Repic O. Blacklock TJ. Tetrahedron Lett.  2001,  42:  1459 ; and references therein
  • 7c Boeckman RK. Clark TJ. Shook BC. Org. Lett.  2002,  4:  2109 
  • 7d Liu G. Tai W.-Y. Li Y.-L. Nan F.-J. Tetrahedron Lett.  2006,  47:  3295 
  • 8 Jacobsen EN. Zhang W. Muci AR. Ecker JR. Deng L. J. Am. Chem. Soc.  1991,  113:  7063 
  • 9 Sharpless KB. Amberg W. Bennani YL. Crispino GA. Hartung J. Jeong KS. Kwong HL. Morikawa K. Wang ZM. Xu D. Zhang XL. J. Org. Chem.  1992,  57:  2768 
  • 10 Frohn M. Dalkiewicz M. Tu Y. Wang ZX. Shi Y.
    J. Org. Chem.  1998,  63:  2948 
  • 11a Padron JM. Kokotos G. Mart T. Markidis T. Gibbons WA. Mart VS. Tetrahedron: Asymmetry  1998,  9:  3381 
  • 11b Adamczyk M. Johnson DD. Reddy RE. Tetrahedron: Asymmetry  1999,  10:  775 
  • 12 Desai D. Sharma AK. Lin J.-M. Krzeminski J. Pimentel M. El-Bayoumy K. Nesnow S. Amin S. Chem. Res. Toxicol.  2002,  15:  64 
  • 13 Sharma AK. Gowdahalli K. Gimbor M. Amin S. Chem. Res. Toxicol.  2008,  21:  154 
  • 14 O’Sullivan TP. Zhang H. Mander LN. Org. Biomol. Chem.  2007,  5:  2627 
  • 15 Liu G. Romo D. Org. Lett.  2008,  11:  1143 
  • 16 Srikrishna A. Babu RR. Tetrahedron  2008,  64:  10501 
  • 17 Brouillette Y. Martinez J. Lisowski V. J. Org. Chem.  2009,  74:  4975